Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Syneos Health, Inc. (INCR) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Syneos Health, Inc.. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 1610950.
Total stock buying since 2015: $915,386.
Total stock sales since 2015: $16,367,309,167.
Total stock option exercises since 2015: $22,479,129.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2022 | 0 | $0 | 24,958 | $1,855,260 | 0 | $0 |
| 2021 | 0 | $0 | 129,347,392 | $10,179,776,918 | 82,199 | $1,960,125 |
| 2020 | 13,546 | $690,683 | 68,040,861 | $4,095,592,634 | 83,048 | $701,471 |
| 2019 | 0 | $0 | 14,840 | $786,781 | 14,840 | $125,397 |
| 2018 | 4,400 | $181,516 | 6,001,470 | $298,440,270 | 0 | $0 |
| 2017 | 0 | $0 | 346,654 | $19,204,417 | 429,781 | $5,165,813 |
| 2016 | 1,000 | $43,187 | 13,786,952 | $606,445,106 | 731,926 | $8,103,778 |
| 2015 | 0 | $0 | 30,501,607 | $1,165,207,781 | 635,739 | $6,422,545 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2017-03-03 | Macdonald Alistair (Chief Executive Officer) | Option Ex | 8,828 | 10.57 | 93,311 |
| 2017-01-20 | Macdonald Alistair (Chief Executive Officer) | Sale | 1,375 | 50.50 | 69,437 |
| 2017-01-20 | Gaenzle Christopher L (CAO, GC & Sec) | Sale | 1,186 | 50.09 | 59,405 |
| 2017-01-20 | Rush Gregory S (Executive VP and CFO) | Sale | 1,573 | 50.50 | 79,436 |
| 2017-01-19 | Rush Gregory S (Executive VP and CFO) | Sale | 1,334 | 50.65 | 67,567 |
| 2017-01-19 | Rush Gregory S (Executive VP and CFO) | Option Ex | 1,334 | 42.88 | 57,201 |
| 2017-01-05 | Macdonald Alistair (Chief Executive Officer) | Sale | 14,840 | 52.19 | 774,440 |
| 2017-01-05 | Macdonald Alistair (Chief Executive Officer) | Option Ex | 14,840 | 8.45 | 125,397 |
| 2017-01-03 | Gaenzle Christopher L (CAO, GC & Sec) | Sale | 30,766 | 51.99 | 1,599,462 |
| 2017-01-03 | Gaenzle Christopher L (CAO, GC & Sec) | Option Ex | 30,766 | 12.23 | 376,268 |
| 2017-01-03 | Rush Gregory S (Executive VP and CFO) | Sale | 41,420 | 52.15 | 2,159,887 |
| 2017-01-03 | Rush Gregory S (Executive VP and CFO) | Option Ex | 41,420 | 13.06 | 540,945 |
| 2016-09-30 | Rush Gregory S (Executive VP and CFO) | Sale | 35,503 | 44.70 | 1,586,913 |
| 2016-09-30 | Rush Gregory S (Executive VP and CFO) | Option Ex | 35,503 | 10.06 | 357,160 |
| 2016-09-27 | Macdonald D. Jamie (Chief Executive Officer) | Sale | 53,970 | 44.30 | 2,391,140 |
| 2016-09-27 | Macdonald D. Jamie (Chief Executive Officer) | Option Ex | 36,688 | 14.79 | 542,615 |
| 2016-09-26 | Breckon Robert W | Sale | 12,197 | 44.30 | 540,388 |
| 2016-09-26 | Breckon Robert W | Option Ex | 7,600 | 8.45 | 64,219 |
| 2016-09-19 | Burgstahler David F (Director) | Buy | 1,000 | 43.19 | 43,187 |
| 2016-09-14 | Gaenzle Christopher L (CAO, GC & Sec) | Sale | 4,734 | 43.14 | 204,234 |
| 2016-09-14 | Gaenzle Christopher L (CAO, GC & Sec) | Option Ex | 4,734 | 10.06 | 47,624 |
| 2016-08-17 | Macdonald Alistair (Chief Operating Officer) | Sale | 8,828 | 43.80 | 386,666 |
| 2016-08-17 | Macdonald Alistair (Chief Operating Officer) | Option Ex | 8,828 | 10.57 | 93,311 |
| 2016-08-04 | 1829356 Ontario Ltd | Sale | 2,445,591 | 42.06 | 102,861,557 |
| 2016-08-04 | Inc Research Mezzanine Co-invest, Llc | Sale | 2,554,409 | 42.06 | 107,438,442 |
| 2016-08-02 | Macdonald D. Jamie (Chief Executive Officer) | Sale | 31,279 | 43.00 | 1,344,997 |
| 2016-08-02 | Macdonald D. Jamie (Chief Executive Officer) | Option Ex | 31,279 | 10.57 | 330,619 |
| 2016-08-01 | Breckon Robert W | Sale | 108 | 42.00 | 4,536 |
| 2016-07-28 | Rush Gregory S (Executive VP and CFO) | Sale | 4,066 | 45.23 | 183,888 |
| 2016-07-28 | Rush Gregory S (Executive VP and CFO) | Option Ex | 4,066 | 40.12 | 163,127 |
| 2016-07-20 | Macdonald D. Jamie (Chief Executive Officer) | Sale | 100,593 | 43.00 | 4,325,499 |
| 2016-07-20 | Macdonald D. Jamie (Chief Executive Officer) | Option Ex | 100,593 | 10.57 | 1,063,268 |
| 2016-07-15 | Rush Gregory S (Executive VP and CFO) | Sale | 5,917 | 41.50 | 245,537 |
| 2016-07-15 | Rush Gregory S (Executive VP and CFO) | Option Ex | 5,917 | 16.06 | 95,027 |
| 2016-07-11 | Macdonald Alistair (Chief Operating Officer) | Sale | 9,468 | 40.19 | 380,499 |
| 2016-07-11 | Macdonald Alistair (Chief Operating Officer) | Option Ex | 9,468 | 16.06 | 152,056 |
| 2016-07-11 | Gaenzle Christopher L (CAO, GC & Sec) | Sale | 21,918 | 40.21 | 881,257 |
| 2016-07-11 | Gaenzle Christopher L (CAO, GC & Sec) | Option Ex | 20,701 | 13.31 | 275,633 |
| 2016-07-01 | Rush Gregory S (Executive VP and CFO) | Sale | 1,358 | 37.97 | 51,563 |
| 2016-07-01 | Breckon Robert W | Sale | 421 | 37.97 | 15,985 |
| 2016-06-15 | Gaenzle Christopher L (CAO, GC & Sec) | Sale | 4,656 | 40.19 | 187,110 |
| 2016-06-15 | Gaenzle Christopher L (CAO, GC & Sec) | Option Ex | 4,656 | 13.31 | 61,994 |
| 2016-06-14 | Gaenzle Christopher L (CAO, GC & Sec) | Sale | 3,046 | 40.08 | 122,089 |
| 2016-06-14 | Gaenzle Christopher L (CAO, GC & Sec) | Option Ex | 3,046 | 13.31 | 40,557 |
| 2016-06-06 | Gibertini Michael (President Clinical Development) | Sale | 213,966 | 43.45 | 9,296,394 |
| 2016-06-06 | Gibertini Michael (President Clinical Development) | Option Ex | 186,096 | 11.69 | 2,176,020 |
| 2016-06-02 | Breckon Robert W | Sale | 2,173 | 43.46 | 94,438 |
| 2016-06-01 | Breckon Robert W | Sale | 9,518 | 43.55 | 414,499 |
| 2016-06-01 | Breckon Robert W | Option Ex | 9,518 | 8.45 | 80,427 |
| 2016-05-06 | 1829356 Ontario Ltd | Sale | 3,912,946 | 45.12 | 176,552,123 |
| 2016-05-06 | Inc Research Mezzanine Co-invest, Llc | Sale | 4,087,054 | 45.12 | 184,407,876 |
| 2016-04-18 | Ogle James T. | Sale | 114,806 | 50.00 | 5,740,300 |
| 2016-04-18 | Ogle James T. | Option Ex | 114,806 | 8.45 | 970,110 |
| 2016-04-12 | Macdonald D. Jamie (Chief Executive Officer) | Sale | 94,675 | 48.00 | 4,544,400 |
| 2016-04-12 | Macdonald D. Jamie (Chief Executive Officer) | Option Ex | 94,675 | 10.57 | 1,000,714 |
| 2016-04-01 | Gibertini Michael (President Clinical Development) | Sale | 9,000 | 40.78 | 367,037 |
| 2016-04-01 | Gibertini Michael (President Clinical Development) | Option Ex | 9,000 | 8.45 | 76,050 |
| 2016-03-01 | Gibertini Michael (President Clinical Development) | Sale | 9,000 | 39.85 | 358,677 |
| 2016-03-01 | Gibertini Michael (President Clinical Development) | Option Ex | 9,000 | 8.45 | 76,050 |
| 2016-02-01 | Gibertini Michael (President Clinical Development) | Sale | 9,000 | 41.01 | 369,045 |
| 2016-02-01 | Gibertini Michael (President Clinical Development) | Option Ex | 9,000 | 8.45 | 76,050 |
| 2016-02-01 | Rush Gregory S (Executive VP and CFO) | Sale | 17,752 | 40.84 | 725,062 |
| 2016-02-01 | Rush Gregory S (Executive VP and CFO) | Option Ex | 17,752 | 16.06 | 285,097 |
| 2016-01-04 | Gibertini Michael (President Clinical Development) | Sale | 9,000 | 46.99 | 422,955 |
| 2016-01-04 | Gibertini Michael (President Clinical Development) | Option Ex | 9,000 | 8.45 | 76,050 |
| 2015-12-31 | Macdonald Alistair (Chief Operating Officer) | Sale | 159,599 | 47.71 | 7,614,468 |
| 2015-12-31 | Macdonald Alistair (Chief Operating Officer) | Option Ex | 112,617 | 11.69 | 1,316,830 |
| 2015-12-31 | Gaenzle Christopher L (CAO, GC & Sec) | Sale | 9,468 | 47.78 | 452,409 |
| 2015-12-31 | Gaenzle Christopher L (CAO, GC & Sec) | Option Ex | 9,468 | 10.31 | 97,662 |
| 2015-12-31 | Rush Gregory S (Executive VP and CFO) | Sale | 35,503 | 47.53 | 1,687,564 |
| 2015-12-31 | Rush Gregory S (Executive VP and CFO) | Option Ex | 35,503 | 10.06 | 357,160 |
| 2015-12-29 | Ogle James T. | Sale | 9,717 | 50.06 | 486,452 |
| 2015-12-29 | Ogle James T. | Option Ex | 9,717 | 8.45 | 82,108 |
| 2015-12-08 | Gaenzle Christopher L (CAO, GC & Sec) | Sale | 14,703 | 40.25 | 591,736 |
| 2015-12-08 | Rush Gregory S (Executive VP and CFO) | Sale | 47,310 | 45.43 | 2,149,293 |
| 2015-12-07 | 1829356 Ontario Ltd | Sale | 4,402,063 | 45.00 | 198,092,835 |
| 2015-12-07 | Macdonald Alistair (Chief Operating Officer) | Sale | 42,959 | 44.98 | 1,932,424 |
| 2015-12-07 | Macdonald Alistair (Chief Operating Officer) | Option Ex | 42,959 | 8.45 | 363,003 |
| 2015-12-07 | Gaenzle Christopher L (CAO, GC & Sec) | Sale | 10,482 | 44.90 | 470,631 |
| 2015-12-07 | Gaenzle Christopher L (CAO, GC & Sec) | Option Ex | 25,185 | 10.31 | 259,783 |
| 2015-12-07 | Inc Research Mezzanine Co-invest, Llc | Sale | 4,597,937 | 45.00 | 206,907,165 |
| 2015-12-07 | Rush Gregory S (Executive VP and CFO) | Sale | 33,725 | 44.90 | 1,514,218 |
| 2015-12-07 | Rush Gregory S (Executive VP and CFO) | Option Ex | 81,035 | 10.06 | 815,212 |
| 2015-12-01 | Gibertini Michael (President Clinical Development) | Sale | 9,000 | 46.60 | 419,363 |
| 2015-12-01 | Gibertini Michael (President Clinical Development) | Option Ex | 9,000 | 8.45 | 76,050 |
| 2015-11-02 | Gibertini Michael (President Clinical Development) | Sale | 9,000 | 41.70 | 375,300 |
| 2015-11-02 | Gibertini Michael (President Clinical Development) | Option Ex | 9,000 | 8.45 | 76,050 |
| 2015-09-28 | Macdonald Alistair (Chief Operating Officer) | Sale | 44,522 | 39.97 | 1,779,544 |
| 2015-09-28 | Macdonald Alistair (Chief Operating Officer) | Option Ex | 44,522 | 8.45 | 376,210 |
| 2015-09-14 | Rush Gregory S (Executive VP and CFO) | Sale | 32,426 | 45.31 | 1,469,222 |
| 2015-09-14 | Rush Gregory S (Executive VP and CFO) | Option Ex | 32,426 | 10.06 | 326,205 |
| 2015-08-31 | Ogle James T. | Sale | 55,000 | 41.12 | 2,261,600 |
| 2015-08-31 | Gaenzle Christopher L (CAO, GC & Sec) | Sale | 17,421 | 41.16 | 717,048 |
| 2015-08-31 | Gaenzle Christopher L (CAO, GC & Sec) | Option Ex | 17,421 | 10.31 | 179,697 |
| 2015-08-17 | 1829356 Ontario Ltd | Sale | 3,857,525 | 44.00 | 169,731,100 |
| 2015-08-17 | Inc Research Mezzanine Co-invest, Llc | Sale | 4,029,168 | 44.00 | 177,283,392 |
| 2015-08-12 | Macdonald D. Jamie (Chief Executive Officer) | Sale | 57,021 | 44.00 | 2,508,924 |
| 2015-08-12 | Macdonald D. Jamie (Chief Executive Officer) | Option Ex | 116,650 | 10.57 | 1,232,990 |
| 2015-08-12 | Breckon Robert W | Sale | 8,381 | 44.00 | 368,764 |
| 2015-08-12 | Breckon Robert W | Option Ex | 3,669 | 8.45 | 31,003 |
| 2015-05-14 | 1829356 Ontario Ltd | Sale | 6,318,607 | 29.68 | 187,536,255 |
| 2015-05-14 | Inc Research Mezzanine Co-invest, Llc | Sale | 6,599,761 | 29.68 | 195,880,906 |
| 2015-05-11 | Ogle James T. | Sale | 2,250 | 29.68 | 66,780 |
| 2015-05-11 | Ogle James T. | Option Ex | 4,191 | 9.51 | 39,856 |
| 2015-05-11 | Rush Gregory S (Executive VP and CFO) | Sale | 1,088 | 29.68 | 32,291 |
| 2015-05-11 | Rush Gregory S (Executive VP and CFO) | Option Ex | 2,301 | 10.06 | 23,148 |
| 2015-05-11 | Breckon Robert W | Sale | 721 | 29.68 | 21,399 |
| 2015-05-11 | Breckon Robert W | Option Ex | 485 | 8.45 | 4,098 |
| 2015-05-07 | Gibertini Michael (President Clinical Development) | Sale | 50,000 | 29.68 | 1,484,000 |
| 2015-05-07 | Ogle James T. | Sale | 25,569 | 29.68 | 758,887 |
| 2015-05-07 | Ogle James T. | Option Ex | 47,814 | 9.51 | 454,711 |
| 2015-05-07 | Rush Gregory S (Executive VP and CFO) | Sale | 12,455 | 29.68 | 369,664 |
| 2015-05-07 | Rush Gregory S (Executive VP and CFO) | Option Ex | 26,250 | 10.06 | 264,075 |
| 2015-05-07 | Breckon Robert W | Sale | 8,226 | 29.68 | 244,147 |
| 2015-05-07 | Breckon Robert W | Option Ex | 5,526 | 8.45 | 46,694 |
Insider trading activities including stock purchases, stock sales, and option exercises of INCR listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Syneos Health, Inc. (symbol INCR, CIK number 1610950) see the Securities and Exchange Commission (SEC) website.